Read More Pharma Industry News Evox Therapeutics secures £35.5m in Series B to advance exosome therapeutics Evox Therapeutics, an innovative biotechnology company spun out from Oxford University, has successfully raised £35.5 million in a… bypharmanewsdailySeptember 4, 2018
